Tilray | TRLY - Trade Debtors

Stock Price
9.33
Daily Change
0.34 3.78%
Monthly
-6.42%
Yearly
1,144.00%
Q2 Forecast
8.92

Tilray reported $109.07M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acasti Pharma USD 20K 0 Sep/2025
Akebia Therapeutics USD 47.03M 19.19M Dec/2025
Alaunos Therapeutics USD 2K 0 Jun/2025
Aurora Cannabis CAD 48.26M 1.53M Dec/2025
Avita Medical AUD 9.11M 2.26M Dec/2025
Canopy Growth CAD 140.42M 113.56M Dec/2025
Cronos Group USD 78.04M 17.64M Dec/2025
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Ionis Pharmaceuticals USD 66M 41.39M Dec/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Moderna USD 184M 862M Dec/2025
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Organon & Co USD 1.48B 0 Sep/2025
Revvity USD 744.67M 64.41M Dec/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 109.07M 2M Sep/2025
Viatris USD 3.03B 340.3M Dec/2025
Xeris Pharmaceuticals USD 51.05M 2.7M Dec/2025
Zealand Pharma A/S 340M 94.1M Dec/2025